Armon Sharei
CIK 1829463 · President and CEO · last filed 2026-04-01
Armon Sharei is a President and CEO who has filed 10 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for GNTA, was dated Apr 1, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
10
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GNTA | Director | — | $1.87 | — | $0 | 1 | 2026-04-01 |
| SQZ Biotechnologies Co (SQZ) Delisted | President and CEO | 287,884 | $0.43 | $125.2K | $0 | 9 | 2022-07-05 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-04-01 | GNTA | Grant (A) | — | $0 | EDGAR |
| 2022-07-05 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | +2,436 | $6.6K | EDGAR |
| 2022-02-15 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-01-13 | SQZ Biotechnologies Co (SQZ) Delisted | Exer (M) | +13,000 | $23.5K | EDGAR |
| 2022-01-04 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | +1,686 | $12.8K | EDGAR |
| 2021-12-22 | SQZ Biotechnologies Co (SQZ) Delisted | Exer (M) | +11,049 | $20.0K | EDGAR |
| 2021-03-02 | SQZ Biotechnologies Co (SQZ) Delisted | Exer (M) | +8,000 | $14.5K | EDGAR |
| 2021-02-25 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-01-12 | SQZ Biotechnologies Co (SQZ) Delisted | Exer (M) | +2,500 | $4.5K | EDGAR |
| 2020-10-30 | SQZ Biotechnologies Co (SQZ) Delisted | Grant (A) | — | $0 | EDGAR |